These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19443835)

  • 1. Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle.
    Anisimov A; Alitalo A; Korpisalo P; Soronen J; Kaijalainen S; Leppänen VM; Jeltsch M; Ylä-Herttuala S; Alitalo K
    Circ Res; 2009 Jun; 104(11):1302-12. PubMed ID: 19443835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
    Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute exercise, exercise training, and diabetes on the expression of lymphangiogenic growth factors and lymphatic vessels in skeletal muscle.
    Kivelä R; Silvennoinen M; Lehti M; Kainulainen H; Vihko V
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2573-9. PubMed ID: 17766486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins.
    Tammela T; He Y; Lyytikkä J; Jeltsch M; Markkanen J; Pajusola K; Ylä-Herttuala S; Alitalo K
    Circ Res; 2007 May; 100(10):1468-75. PubMed ID: 17478733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
    Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
    Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus-mediated vascular endothelial growth factor gene therapy in skeletal muscle before transplantation promotes revascularization of regenerating muscle.
    Smythe GM; Lai MC; Grounds MD; Rakoczy PE
    Tissue Eng; 2002 Oct; 8(5):879-91. PubMed ID: 12459067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation.
    Bry M; Kivelä R; Holopainen T; Anisimov A; Tammela T; Soronen J; Silvola J; Saraste A; Jeltsch M; Korpisalo P; Carmeliet P; Lemström KB; Shibuya M; Ylä-Herttuala S; Alhonen L; Mervaala E; Andersson LC; Knuuti J; Alitalo K
    Circulation; 2010 Oct; 122(17):1725-33. PubMed ID: 20937974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localisation of lymphatic vessels and vascular endothelial growth factors-C and -D in human and mouse skeletal muscle with immunohistochemistry.
    Kivelä R; Havas E; Vihko V
    Histochem Cell Biol; 2007 Jan; 127(1):31-40. PubMed ID: 16924525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein.
    Keskitalo S; Tammela T; Lyytikka J; Karpanen T; Jeltsch M; Markkanen J; Yla-Herttuala S; Alitalo K
    Circ Res; 2007 May; 100(10):1460-7. PubMed ID: 17478734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural determinants of vascular endothelial growth factor-D receptor binding and specificity.
    Leppänen VM; Jeltsch M; Anisimov A; Tvorogov D; Aho K; Kalkkinen N; Toivanen P; Ylä-Herttuala S; Ballmer-Hofer K; Alitalo K
    Blood; 2011 Feb; 117(5):1507-15. PubMed ID: 21148085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated gene transfer of human vascular endothelial growth factor-d induces transient angiogenic effects in mouse hind limb muscle.
    Kholová I; Koota S; Kaskenpää N; Leppänen P; Närväinen J; Kavec M; Rissanen TT; Hazes T; Korpisalo P; Gröhn O; Ylä-Herttuala S
    Hum Gene Ther; 2007 Mar; 18(3):232-44. PubMed ID: 17362136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
    Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K
    Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds.
    Saaristo A; Tammela T; Timonen J; Yla-Herttuala S; Tukiainen E; Asko-Seljavaara S; Alitalo K
    FASEB J; 2004 Nov; 18(14):1707-9. PubMed ID: 15361472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor B promotes transendothelial fatty acid transport into skeletal muscle via histone modifications during catch-up growth.
    Lu X; Hu S; Liao Y; Zheng J; Zeng T; Zhong X; Liu G; Gou L; Chen L
    Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1031-E1043. PubMed ID: 32954823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An important role of lymphatic vessel activation in limiting acute inflammation.
    Huggenberger R; Siddiqui SS; Brander D; Ullmann S; Zimmermann K; Antsiferova M; Werner S; Alitalo K; Detmar M
    Blood; 2011 Apr; 117(17):4667-78. PubMed ID: 21364190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia.
    Kuwahara G; Nishinakamura H; Kojima D; Tashiro T; Kodama S
    J Vasc Surg; 2013 Apr; 57(4):1090-9. PubMed ID: 23219511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel.
    Aspelund A; Tammela T; Antila S; Nurmi H; Leppänen VM; Zarkada G; Stanczuk L; Francois M; Mäkinen T; Saharinen P; Immonen I; Alitalo K
    J Clin Invest; 2014 Sep; 124(9):3975-86. PubMed ID: 25061878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
    Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
    J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.